Literature DB >> 23838570

USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.

G B Srinivas1, A Walker, B Rippke.   

Abstract

Batch-release potency testing of leptospiral vaccines licensed by the United States Department of Agriculture (USDA) historically was conducted through animal vaccination-challenge models. The hamster vaccination-challenge assay was Codified in 1974 for bacterins containing Leptospira pomona, Leptospira icterohaemorrhagiae, and Leptospira canicola, and in 1975 for bacterins containing Leptospira grippotyphosa. In brief, 10 hamsters are vaccinated with a specified dilution of bacterin. After a holding period, the vaccinated hamsters, as well as nonvaccinated controls, are challenged with virulent Leptospira and observed for mortality. Eighty percent of vaccinated hamsters must survive in the face of a valid challenge. The high cost of the Codified tests, in terms of monetary expense and animal welfare, prompted the Center for Veterinary Biologics (CVB) to develop ELISA alternatives for them. Potency tests for other serogroups, such as Leptospira hardjo-bovis, that do not have Codified requirements for potency testing continue to be examined on a case-by-case basis. Published by Elsevier Ltd.

Entities:  

Keywords:  Leptospira; Leptospirosis; Potency testing; Regulatory testing; Standard Requirements; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 23838570     DOI: 10.1016/j.biologicals.2013.06.005

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  5 in total

Review 1.  Human leptospirosis vaccines in China.

Authors:  Yinghua Xu; Qiang Ye
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

2.  Replacement of in vivo leptospirosis vaccine potency testing in the United States.

Authors:  Bridget Rogers; Jeffrey Brown; David G Allen; Warren Casey; Amy J Clippinger
Journal:  Biologicals       Date:  2022-06-24       Impact factor: 1.760

3.  A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?

Authors:  André Alex Grassmann; Jéssica Dias Souza; Alan John Alexander McBride
Journal:  Front Immunol       Date:  2017-03-09       Impact factor: 7.561

4.  LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.

Authors:  Neida L Conrad; Flávia W Cruz McBride; Jéssica D Souza; Marcelle M Silveira; Samuel Félix; Karla S Mendonça; Cleiton S Santos; Daniel A Athanazio; Marco A Medeiros; Mitermayer G Reis; Odir A Dellagostin; Alan J A McBride
Journal:  PLoS Negl Trop Dis       Date:  2017-03-16

5.  Transcriptome and proteome analysis of innate immune responses to inactivated Leptospira and bivalent Leptospira vaccines in canine 030-D cells.

Authors:  Andreja Novak; Jeroen L A Pennings; Larissa van der Maas; Hugo D Meiring; Irene Ludwig; Saertje Verkoeijen; Victor Rutten; Femke Broere; Arjen Sloots
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.